BUCCOLAM

उत्पाद अवलोकन

About BUCCOLAM

Buccolam is a prescription medication containing the active ingredient midazolam hydrochloride, a benzodiazepine used for the treatment of seizures in patients with Lennox-Gastaut syndrome (LGS). It is administered via buccal administration, allowing for rapid absorption into the bloodstream.

Key Benefits & Uses

• Treatment of seizures in patients with Lennox-Gastaut syndrome (LGS)
• Effective management of seizure frequency and severity in LGS patients
• Convenient buccal administration for rapid absorption and onset of action

Active Ingredient & Action

Midazolam hydrochloride, the active ingredient in Buccolam, is a potent benzodiazepine that acts on the central nervous system to produce sedative, hypnotic, and anticonvulsant effects. It binds to GABA receptors, enhancing the activity of the neurotransmitter gamma-aminobutyric acid (GABA), which has a calming effect on the brain and nervous system, thereby reducing the frequency and severity of seizures in LGS patients.

Important Notes

It is essential to use Buccolam as directed by a healthcare professional and to follow the recommended dosage and administration instructions. Buccolam may cause drowsiness, dizziness, and impaired cognitive function, and patients should avoid operating heavy machinery or engaging in hazardous activities until they are aware of the effects of the medication. Regular monitoring of seizure frequency and severity is crucial to ensure the effectiveness of treatment and to adjust the dosage as needed.